TLR9 and hepatocellular carcinoma: A downregulation of TLR9 due to the single nucleotide polymorphism of the TLR9 promoter -1486T/C has been previously implied in impaired innate immunity (191), and also recently been associated with an increased risk of HCC recurrence after liver transplantation (192).